Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy
G Mitacchione, M Schiavone, A Curnis, M Arca… - Journal of clinical …, 2021 - Elsevier
Background Epidemiological evidence suggests that anti-inflammatory and
immunomodulatory properties of statins may reduce the risk of infections and infection-
related complications. Objective We aimed to assess the impact of prior statin use on
coronavirus disease (COVID-19) severity and mortality. Methods In this observational
multicenter study, consecutive patients hospitalized for COVID-19 were enrolled. In-hospital
mortality and severity of COVID-19 assessed with National Early Warning Score (NEWS) …
immunomodulatory properties of statins may reduce the risk of infections and infection-
related complications. Objective We aimed to assess the impact of prior statin use on
coronavirus disease (COVID-19) severity and mortality. Methods In this observational
multicenter study, consecutive patients hospitalized for COVID-19 were enrolled. In-hospital
mortality and severity of COVID-19 assessed with National Early Warning Score (NEWS) …